Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans
Johnson & Johnson Stephen Siller Tunnel to Towers Foundation Tunnel
Members of the military participate in the Tunnel to Towers 5K Run & Walk

How Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation are making a difference for military veterans

Members of the military participate in the Tunnel to Towers 5K Run & Walk

Support for our nation’s soldiers is part of Johnson & Johnson’s DNA.

In the 1800s, the company was integral to spreading the word about the importance of sterile care for wounds sustained on the battlefield, thanks to its innovations in surgical dressings and sutures. And during the Spanish-American War, Johnson & Johnson did something groundbreaking and continued to pay employees their salaries, and held their positions for them, while they served.

That legacy continues to this day, from policies that make it easier for service members on leave to transition back into their day-to-day lives to partnerships that give them the skills and resources they need to thrive.

Partnerships like the one between Johnson & Johnson and the Stephen Siller Tunnel to Towers Foundation, which was founded in 2001 to help military veterans and first responders and their families.

In honor of the 16th annual Tunnel to Towers 5K Run & Walk on September 24, we’re taking a look at how both organizations have joined forces to be there for service members over the past three years.

Tunnel to Towers infographic

More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.